Guidance on Acknowledgement of Support for Manuscripts Resulting from HPTN Funded Studies
Per Section 1.7 of HPTN Operating Policy HPTN011-09, all publications and presentations will include a statement acknowledging the HPTN and NIH's support for the work and listing the applicable cooperative agreement numbers, unless the journal's policy precludes such an acknowledgment. Several of the suggested acknowledgements below require adding cooperative agreement numbers, a list of cooperative agreement numbers for participating organizations is available here.
If other institutions at NIH provided additional funding and/or support for your study, an acknowledgement of that support is also required. Contact your Project Officer at that institute for guidance.
If you have any questions regarding these acknowledgments or other concerns please contact Karen Quick (kquick@fhi360 .org).
For U.S. Domestic and International HPTN II funded
studies under Award Number
UM1 AI068619
The project described was supported by Award Number UM1 AI068619 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.
Acknowledgement of support for manuscripts resulting from International studies funded by HPTN I and then transitioned to MTN or IMPAACT should the following HPTN acknowledgement.
This work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations)
This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35173 with Family Health International; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with (name the sites). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).
This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35173 with Family Health International; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with (name the sites). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).
This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35176 with Abt Associates Inc.; contract N01-AI-35173 with Family Health International; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with (name the sites). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).
This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Alcohol Abuse and Alcoholism (NIAAA), of the National Institutes of Health, Department of Health and Human Services, through contract N01-AI-35176 with Abt Associates Inc.; contract N01-AI-45200 with Fred Hutchinson Cancer Research Center; subcontracts with (Denver Department of Health and Hospitals, Fenway Community Health Center, Howard Brown Health Center, New York Blood Center, Public Health Foundation, Inc.). In addition, this work was supported by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), and Office of AIDS Research (OAR), of the National Institutes of Health, U.S. Department of Health and Human Services (list the cooperative agreement numbers of participating HPTN organizations).
